FDA.reportPublic FDA data

Crysvita 30 MG per 1 ML Injection

RxCUI
2043878
RxNorm name
Crysvita 30 MG per 1 ML Injection
Display name
Crysvita 30 MG per 1 ML Injection
Full name
Crysvita 30 MG per 1 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761068Crysvitaburosumab-twza351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CRYSVITABUROSUMABKyowa Kirin, Inc.102f96a0-6e3a-4fc1-b204-34d604683af62026-04-22Warnings, Adverse reactionsExact identifier
rxcui: 2043878

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
102f96a0-6e3a-4fc1-b204-34d604683af6CRYSViTA 30 MG in 1 ML Injection [PSN] · 1 ML burosumab-twza 30 MG/ML Injection [Crysvita] [SBD] · Crysvita 30 MG per 1 ML Injection [SY]35These highlights do not include all the information needed to use CRYSVITA safely and effectively. See full prescribing information for CRYSVITA. CRYSVITA ® (burosumab-twza) injection, for subcutaneous use Initial U.S. Approval: 201820250904